Assessment of potential of AgNOR counts as tumor marker in cervical carcinogenesis

Diagnostic Cytopathology

Volumn 36, Issue 3, 2008, Pages 194-195

  Misra, Jata S ^a   Chhavi, ^a   Singh, Madhulika ^a   Srivastava, Anand N ^a   Das, Vinita ^a  

^a UNIVERSITY OF LUCKNOW   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER CYTODIAGNOSIS; CANCER SCREENING; CHROMOSOME NOR; DIAGNOSTIC VALUE; HUMAN; LETTER; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ANTIGENS; ANTIGENS, NUCLEAR; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 39749085337     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20718     Document Type: Letter

References (4)

1. Cardillo MR. AgNOR counts are useful in cervical smears. Diag Cytopathol 1992;60:208-210.
2. Florella RN, Saron B, Kanagel PI. AgNOR counts as discriminator of the lesions of the endocervix. Acta Cytol 1994;38:528-530.
3. Edelson OV, Morilla DS. Siliver staining method for nucleolar organizer regions in cervical smears. Diag Cytopathol 1996;16:497-499.
4. Misra JS, Das V, Srivastava AN, et al. AgNOR counts in cervical smears under normal and other cytopathologic conditions. J Quant Anal Cytol Histol 2005;27:337-340.